Trump reclassification order leaves South Dakota marijuana outlook uncertain

A federal reclassification push arrives as South Dakota's medical market grows 62% year-over-year amid mixed state-level regulatory signals.

FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0

A Trump administration order seeking marijuana reclassification could reshape South Dakota's cannabis landscape, though immediate state-level impact remains unclear, according to reporting by the Argus Leader. South Dakota has maintained a functional medical marijuana program while rejecting broader legalization efforts—state senators rejected repeal bills as recently as February 2026 and voted against debate on intoxicating hemp bans that same month.

Market momentum suggests regulatory openness to medical access: medical marijuana cardholders rose 62% year-over-year as of April 2026, and border-town markets continued expanding. Meanwhile, law enforcement activity persists—federal and state agencies have seized over 280 pounds of marijuana in major busts since mid-2026, and one Wisconsin trafficker pleaded guilty to I-90 trafficking charges. The state also eliminated its medical marijuana oversight committee in February.

Whether federal reclassification accelerates South Dakota's medical expansion or triggers stricter federal enforcement remains the key variable. Watch for state legislative response in the next session and any shifts in how South Dakota's existing medical program is implemented.